Cytosorbents (CTSO) Tops Q1 EPS by 1c

Cytosorbents (NASDAQ: CTSO) reported Q1 EPS of ($0.12), $0.01 better than the analyst estimate of ($0.13). Revenue for the quarter came in at $9.78 million versus the consensus estimate of $9.78 million.

For earnings history and earnings-related data on Cytosorbents (CTSO) click here.

You May Also Be Interested In

• Jefferies upgrades Shopify to Buy on AI commerce tailwinds, sees 30% upside
• Gold Royalty acquires two Nevada royalties for $0.8 million
• Morgan Stanley Downgrades Tryg A/S (TRYG:DC) (TGVSF) to Underweight